Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Mar;41(3):661–664. doi: 10.1128/aac.41.3.661

Development of a high-performance liquid chromatographic assay for G418 sulfate (Geneticin).

C Bethune 1, T Bui 1, M L Liu 1, M A Kay 1, R J Ho 1
PMCID: PMC163768  PMID: 9056010

Abstract

We have developed a chromatographic assay with high sensitivity and specificity to quantify G418 sulfate (Geneticin), an antibiotic used routinely in molecular genetics experiments for selecting eukaryotic transformants. With this method, G418 in tissues and plasma samples can be quantitated without the confounding factors often associated with biological assays. After removal of proteins in homogenized tissue or plasma samples with methanol (2:1, vol/vol), the amino group of G418 was derivatized with 1-fluoro-2,4-dinitrobenzene (DNFB) to form the UV-visible G418-DNFB product. The DNFB-derivatized G418 was separated on a reversed-phase C18 column with an acetonitrile and water gradient as the mobile phase. Under these assay conditions, the detection limit for G418 sulfate in buffer, plasma, and tissues was recorded at 78 ng/ml and the linearity was recorded for concentrations up to 100 micrograms/ml. The data obtained from this analysis indicate that this assay can be used for the quantitative determination of G418 sulfate in plasma and tissue samples.

Full Text

The Full Text of this article is available as a PDF (74.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aran J. M., Gottesman M. M., Pastan I. Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3176–3180. doi: 10.1073/pnas.91.8.3176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barends D. M., Blauw J. S., Smits M. H., Hulshoff A. Determination of amikacin in serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr. 1983 Sep 9;276(2):385–394. doi: 10.1016/s0378-4347(00)85105-1. [DOI] [PubMed] [Google Scholar]
  3. Barends D. M., van der Sandt J. S., Hulshoff A. Micro determination of gentamicin in serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr. 1980 May 9;182(2):201–210. doi: 10.1016/s0378-4347(00)81624-2. [DOI] [PubMed] [Google Scholar]
  4. Blaese R. M., Culver K. W., Miller A. D., Carter C. S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science. 1995 Oct 20;270(5235):475–480. doi: 10.1126/science.270.5235.475. [DOI] [PubMed] [Google Scholar]
  5. Bordignon C., Notarangelo L. D., Nobili N., Ferrari G., Casorati G., Panina P., Mazzolari E., Maggioni D., Rossi C., Servida P. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science. 1995 Oct 20;270(5235):470–475. doi: 10.1126/science.270.5235.470. [DOI] [PubMed] [Google Scholar]
  6. Essers L. An automated high-performance liquid chromatographic method for the determination of aminoglycosides in serum using pre-column sample clean-up and derivatization. J Chromatogr. 1984 Feb 10;305(2):345–352. doi: 10.1016/s0378-4347(00)83348-4. [DOI] [PubMed] [Google Scholar]
  7. Fang B., Eisensmith R. C., Wang H., Kay M. A., Cross R. E., Landen C. N., Gordon G., Bellinger D. A., Read M. S., Hu P. C. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther. 1995 Aug;6(8):1039–1044. doi: 10.1089/hum.1995.6.8-1039. [DOI] [PubMed] [Google Scholar]
  8. Hadfield C., Jordan B. E., Mount R. C., Pretorius G. H., Burak E. G418-resistance as a dominant marker and reporter for gene expression in Saccharomyces cerevisiae. Curr Genet. 1990 Nov;18(4):303–313. doi: 10.1007/BF00318211. [DOI] [PubMed] [Google Scholar]
  9. Jimenez A., Davies J. Expression of a transposable antibiotic resistance element in Saccharomyces. Nature. 1980 Oct 30;287(5785):869–871. doi: 10.1038/287869a0. [DOI] [PubMed] [Google Scholar]
  10. Kay M. A., Woo S. L. Gene therapy for metabolic disorders. Trends Genet. 1994 Jul;10(7):253–257. doi: 10.1016/0168-9525(94)90173-2. [DOI] [PubMed] [Google Scholar]
  11. Kotani H., Newton P. B., 3rd, Zhang S., Chiang Y. L., Otto E., Weaver L., Blaese R. M., Anderson W. F., McGarrity G. J. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther. 1994 Jan;5(1):19–28. doi: 10.1089/hum.1994.5.1-19. [DOI] [PubMed] [Google Scholar]
  12. Loebenberg D., Counels M., Waitz J. A. Antibiotic G418, a new micrommomospora-produced aminglycoside with activity apainst protozoa and helminths: antiparasitic activity. Antimicrob Agents Chemother. 1975 Jun;7(6):811–815. doi: 10.1128/aac.7.6.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Metz M. Z., Matsumoto L., Winters K. A., Doroshow J. H., Kane S. E. Bicistronic and two-gene retroviral vectors for using MDR1 as a selectable marker and a therapeutic gene. Virology. 1996 Mar 1;217(1):230–241. doi: 10.1006/viro.1996.0110. [DOI] [PubMed] [Google Scholar]
  14. Sanger F. The free amino groups of insulin. Biochem J. 1945;39(5):507–515. doi: 10.1042/bj0390507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sokolic R. A., Sekhsaria S., Sugimoto Y., Whiting-Theobald N., Linton G. F., Li F., Gottesman M. M., Malech H. L. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood. 1996 Jan 1;87(1):42–50. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES